Evidence map›Paper›PMID 42807748›Full record

ArticleDystonia (Lausanne, Switzerland)2026

Beyond the Neck: Long-Term Motor and Non-motor Outcomes of Pallidal DBS in Craniocervical Dystonia.

Matthew Remz, Pamela Zeilman, Samyukta Senthil, Rohini Kumar, Isabelle Gerzenshtein, Hikaru Kamo, Aparna Wagle Shukla

Abstract read
In one paragraph

Article in Dystonia (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthew RemzDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.
Pamela ZeilmanDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.
Samyukta SenthilDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.
Rohini KumarDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.
Isabelle GerzenshteinDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.
Hikaru KamoDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.
Aparna Wagle ShuklaDepartment of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, Florida, United States of America.

Funding

Progressive resistance exercise and dystonia pathophysiology.R01NS122943 · NINDS · UNIVERSITY OF FLORIDA · PI Aparna Wagle Shukla · 2022 to 2026
$2.5M
Cerebellar and Basal Ganglia Markers Underlie Neuromotor Impairments in Adults with Autism Spectrum Disorder (ASD)R01NS121120 · NINDS · UNIVERSITY OF FLORIDA · PI WANG, ZHENG · 2021 to 2025
$1.9M
NINDS NIH HHS R01 NS121120NINDS NIH HHS R01 NS122943
6 · The paper itself

Abstract

Pallidal deep brain stimulation (DBS) is effective for treating cranial or craniocervical dystonia, a disorder characterized by abnormal facial expressions, impaired eyelid opening, speech and chewing difficulties, and abnormal head posture, leading to physical disability and functional impairment. However, long-term data on motor, non-motor, and quality-of-life outcomes remain limited with less robust available data than cervical dystonia. In 19 patients with craniocervical dystonia, the Unified Dystonia Rating Scale (UDRS) scores improved by 34.5% at 3-6 months, 51.0% at 1-2 years, 33.3% at 3-5 years, and 43.4% at the most recent follow-up (median of individual improvements). Body region analysis showed that the proportion of patients classified as DBS responders, defined by a ≥ 25-30% improvement in UDRS scores, ranged from 31.2% to 43.8% at 3-6 months, increasing to a range of 50% to 83.3% by the 6-9-year follow-up. Alongside motor improvements, trends in depression and social quality-of-life domain improvements were noted with more robust changes likely limited by sample size and the lack of disease specific metrics. Longer therapy duration appeared to enhance the magnitude of gains. Overall, pallidal DBS improves motor function and daily activities in craniocervical dystonia, with durable and potentially progressive long-term benefits.

Indexed as

blepharospasmcraniocervical DBSGPilong-termMeige syndrome

Identifiers

PMID42807748
PMCPMC13618971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.